¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"maternal serum screening"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® screening ÇÑ±Û °Ë»ö, ¼±º°
¼³¸í   
  1. º¸±â¿¡´Â °Ç°­ÇÑ °Í°ú °°ÀÌ º¸À̸鼭 Áúº´¿¡ °É·ÁÀÖ´Ù°í »ý°¢µÇ´Â »ç¶÷µéÀ» °ñ¶ó³»±â À§ÇÑ °Ë»ç. Áúº´ÀÇ Áø´ÜÀ» ÀǵµÇÑ °ÍÀº ¾Æ´Ï°í ´Ù¼öÀÇ ¼öÀüÀÚ Áß¿¡¼­ ºñ±³Àû °£´ÜÇÑ ¹æ¹ýÀ¸·Î ÀǽÉÀÌ °¡´Â ÀÚ¸¦ °ñ¶ó³»´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. ¼±ÃâµÈ Àڴ ´õ¿í »ó¼¼ÇÑ °Ë»ç¸¦ ¹ÞÀ» Çʿ䰡 ÀÖ´Ù. 2. ½ÃÇèÀ̳ª °Ë»ç¿Í °°Àº ¿¹ºñÀû ÀýÂ÷, Á¶»ç°¡ ´õ ÇÊ¿äÇÑ Àå¾ÖÀÇ °¡Àå Æ¯Â¡ÀûÀΠ¡Èĸ¦ Ã£¾Æ³»±â À§ÇØ ½ÃÇàÇÑ´Ù. 3. Áý´Ü¼±º°°Ë»ç, °íÇ÷¾Ð°ú °°Àº Æ¯Á¤º´À̳ª Àå¾Ö¸¦ Ã£¾Æ³»±â À§ÇØ Å« Ç¥º»À» ÀÌ¿ëÇϴ °Ë»ç.
¿µ¹® serum ÇÑ±Û Ç÷û
¼³¸í   
  Ç÷¾×ÀÇ ¼ººÐ Áß °íÇü¼ººÐÀΠÇ÷±¸¼¼Æ÷(ÀûÇ÷±¸, ¹éÇ÷±¸ µî), Ç÷¼ÒÆÇÀ» Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ÀåÀ̶ó°í Çϰí, Ç÷Àå¿¡¼­ ¼¶À¯¼Ò¸¦ Á¦¿ÜÇÑ ºÎºÐÀ» Ç÷ûÀ̶ó°í ÇÑ´Ù.
¿µ¹® serum proteins ÇÑ±Û Ç÷û´Ü¹é
¼³¸í   
  Ç÷û¿¡ Àִ ´Ü¹éÁúµéÀ» ÃÑĪÇϴ ¸»·Î, ¸é¿ª±Û·ÎºÒ¸°(¸é¿ªÇö»ó¿¡ °ü¿©Çϴ Ç×ü¸¦ Çü¼ºÇÔ), ¾ËºÎ¹Î, º¸Ã¼ ¹× ÀÀ°íÀÎÀÚ¿Í ¿©·¯ È¿¼ÒµéÀÌ ÀÌ¿¡ ¼ÓÇÑ´Ù.
¿µ¹® serum enzyme ÇÑ±Û Ç÷ûȿ¼Ò
¼³¸í   
  Ç÷û ³»¿¡ Æ÷ÇԵǾî Àִ ¿©·¯ °¡Áö È¿¼Ò¸¦ ÀÏÄ´ ¸»ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maternal serum screening
    ¸ðüÇ÷û¼±º°°Ë»ç
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • Denver Developmental Screening Test
    µ§¹ö¹ß´Þ¼±º°°Ë»ç
  • genetic screening
    À¯Àü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • multiphasic screening
    ´Ù»ó¼±º°°Ë»ç
  • mass screening
    Áý´Ü¼±º°°Ë»ç
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
  • prescriptive screening
    ó¹æÀû¼±º°°Ë»ç
  • screening
    °Ë»ö, ¼±º°°Ë»ç
  • screening program
    Áý´Ü°ËÁø»ç¾÷, À¯¼Ò°ßÀڹ߰߻ç¾÷
  • screening test
    ¼±º°°Ë»ç
  • maternal
    ¸ð¼º-, ¸ðü-, ¸ð°è-
  • maternal and child health
    ¸ðÀÚº¸°Ç
  • maternal antibody
    ¸ðüÇ×ü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maternal
    ¸ð¼º-
  • feto-maternal transfusion
    žƸðü¼öÇ÷
  • maternal welfare
    ¸ð¼ºº¹Áö
  • serum hepatitis
    Ç÷û°£¿°
  • screening
    °Ë»ö, ¼±º°, °Ë»ç
  • serum
    Ç÷û
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
  • serum sickness
    Ç÷ûº´
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • screening test
    ¼±º°°Ë»ç
  • serum typing
    Ç÷ûÇü°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • mass screening
    Áý´Ü°Ë»ç
  • multiphasic screening
    ´Ù´Ü°è¼±º°, ´Ù»ó°ËÁø
  • multiphasic screening test
    ´Ù»ó¼±º°°Ë»ç
  • prescriptive screening
    ó¹æÀû¼±º°¹æ¹ý
  • screening program
    Áý´Ü°ËÁø»ç¾÷, À¯¼Ò°ßÀڹ߰߻ç¾÷
  • screening coordinate recorder
    ÁÖ»ç½ÄÁÂÇ¥±â·Ï±â
  • screening
    °Ë»ö, ¼±º°
  • screening test
    ¼±º°°Ë»ç
  • screening hearing test
    ¼±º°Ã»·Â°Ë»ç
  • maternal antibody
    ¸ðüÇ×ü
  • maternal behavior
    ¸ð¼ºÇൿ
  • maternal blood
    ¸ðüÇ÷¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody, maternal
    ¸ðüÇ×ü
  • immunity, maternal
    ¸ð¼º¸é¿ª
  • inheritance, maternal
    ¸ð¼ºÀ¯Àü
  • DDST=Denver developmental screening test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç(Û¡Ó¹ðàÞÛËþÞÛ)
  • Denver developmental screening test
    µ§¹ö¹ßÀ°¼±º°¹ý.
  • Falcon assay screening test
    ÆÈÄܺм®¼±º°½ÃÇè
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º° °Ë»ç.
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
  • Cattanis serum
    īŸ´Ï¾×.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º° °Ë»ç.
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • multiphasic health screening
    ´Ù»ó½Ä °Ç°­°ËÁø.
  • multiphasic screening
    ´Ù»ó¼º ¼±º°°Ë»ç.
  • multiphasic screening test
    ´Ù»ó¼º(ËÀË×ËÛ) ½ºÅ©¸®´× Å×½ºÆ®.
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • prescreening development questionnaire for Denver developmental screening test
  • screening
    ½ºÅ©¸®´×
  • screening [method]
    °Ë»ö(¹ý)
  • screening coordinate recorder
    ÁÖ»ç½ÄÁÂÇ¥±â·Ï±â(ñËÞÛãÒñ¨øöÑÀÒÓÐï).
  • screening hearing test
    ¼±º°Ã»·Â°Ë»ç
  • screening procedure
    ¼±º°ÀÛ¾÷
  • screening program
    Áý´Ü°ËÁø»ç¾÷(̤ËÀ˧̤Ë×Ëâ), À¯¼Ò°ßÀڹ߰߻ç¾÷.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Maternal part
    ¸ðüºÎºÐ
    [¿¾ ¿ë¾î] ¸ðüºÎ
  • Maternal parts
    ¸ðüºÎºÐ
    [¿¾ ¿ë¾î] ¸ðüºÎ
  • Maternal cotyledon
    ¸ðüÂÊŹݿ±
    [¿¾ ¿ë¾î] ¸ðÃøÅ¹ݿ±
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mass screening
    Áý´Ü°Ë»ç
  • screening test
    ¼±º°°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute serum
    ±Þä Ç÷û(Ðáóõúìôè)
  • antilymphocyte serum
    Ç×Àӯı¸Ç÷û(ù÷×ú÷éϹúìôè)
  • blood serum
    Ç÷û(úìôè)
  • immune serum
    ¸é¿ª Ç÷û(Øóæ¹úìôè)
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
  • serum
    Ç÷û(úìôè)
  • serum Ac globulin
    Ç÷û(úìôè) Ac±Û·ÎºÒ¸°
  • serum albumin
    Ç÷û(úìôè) ¾ËºÎ¹Î
  • serum converting enzyme
    Ç÷û Àüȯ È¿¼Ò(úìôèï®üµý£áÈ)
  • serum folate
    Ç÷û(úìôè) Æú»ê(ß«)
  • serum proteins
    Ç÷û ´Ü¹éÁú(úìôèÓ±ÛÜòõ)
  • serum prothrombin conversion accelerator
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÃËÁøÁ¦(ï®üµõµòäð¥)
  • serum prothrombin converting factor
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÀÎÀÚ(ï®üµì×í­)
  • serum sulfation factor
    Ç÷û À¯È²È­ÀÎÀÚ(úìôè×¼üÜûùì×í­)
  • serum thymic factor
    Ç÷û °©»ó¼±ÀÎÀÚ(úìôèË£ßÒàÍì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maternal
    ¸ð¼ºÀÇ
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • screening
    ½ºÅ©¸®ÀÌ´×, ¼±º°¹ý
  • screening test
    ¼±º°°Ë»ç, ¿¹ºñ°Ë»ç
  • radioiodinated serum albumin
    ¹æ»ç¼±¿ä¿ÀµåÈ­Ç÷û¾ËºÎ¹Î
  • serum
    Ç÷û
  • serum amylase
    Ç÷û¾Æ¹Ð¶ó¾ÆÁ¦
  • serum creatinine
    Ç÷ûũ·¹¾ÆÆ¼´Ñ
  • serum protein
    Ç÷û´Ü¹é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
MHP hemiplegic migraine; maternal health program; maternal health program; medical center health plan; 1...
MDS Master of Dental Surgery; maternal deprivation syndrome; medical data screening; medical data system...
HSP Health Systems Plan; heat shock protein; hemostatic screening profile; Henoch-Schonlein purpura; her...
DAST drug abuse screening test; drug and alcohol screening test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSS Maternal Serum Screening
MSAFP Maternal Serum Alpha Feto Protein
MS Maternal serum
MShCG maternal serum human chorionic gonadotropin
AMA Advanced maternal age
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Denver developmental screening test
    µ§¹ö ¹ßÀ° ¼±º° °Ë»ç, µ§¹ö ¹ßÀ° ¼±º°¹ý
    ¹ßÀ° ºÎÁøÀÌ ÀÖ´Â ¿µ¾Æ³ª ÇÐ·É Àü±â ¾Æµ¿À» ½Äº°ÇÏ´Â °Ë»ç¹ý.
  • screening device
    °Ë»ö ±â±â
  • screening examination
    °£ÀÌ °Ë»ç
  • screening history
    °£ÀÌ º´·Â Á¶»ç
  • screening test
    ¼±º° °Ë»ç, ¿¹ºñ °Ë»ç
  • fetal placental-maternal interrelation
    žÆ-ŹÝ-¸ðü »óÈ£ °ü°è
  • maternal
    ¸ð¼ºÀÇ
  • maternal behavior
    ¸ð¼º Çൿ
  • maternal death rate
    ¸ð¼º »ç¸Á·ü
  • maternal health
    ¸ð¼º º¸°Ç
  • maternal mortality rate
    ¸ð¼º »ç¸Á·ü, ÀÓ»êºÎ »ç¸Á·ü
  • acute phase serum
    ±Þ¼º º´±â Ç÷û
  • acute serum sickness
    ±Þ¼º Ç÷ûº´
    Àü½Å¼º ¸é¿ªº¹ÇÕü ÁúȯÀÇ ÀüÇüÀûÀÎ ¿¹ÀÌ´Ù. Çѵ¿¾È Çǵ¿¼º ¸é¿ªÀ» À§ÇØ »ç¿ëµÈ ´Ù·®ÀÇ ÀÌÁ¾ Ç÷ûÀÇ Åõ¿©¿¡ µû¸¥ ÈÄÀ¯ÁõÀÌ´Ù.
  • Banzhaf serum
    ¹ÝÃ÷ÇÏÇÁ Ç÷û
    ³óÃà Ç×Æó¿°±Õ Ç÷û.
  • Bardel's serum
    ¹Ù¾Æµ¨ Ç÷û
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
maternal serum alpha-fetoprotein A plasma protein, alpha-fetoprotein (afp) is normally produced by the foetus. The level of afp in the blood serum of pregnant women provides a screening test for open neural tube defects (anencephaly and spina bifida) and for down syndrome (and other chromosome abnormalities). The maternal serum afp (msafp) tends to be unusally high with open neural tube defects and unsually low with down syndrome.
(12 Dec 1998)
cancer, colon: screening and surveillance Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer.
(12 Dec 1998)
genetic screening The process of testing individuals to find out if they carry genes for certain known genetic diseases, such as sickle cell anaemia.
(09 Oct 1997)
carrier screening Indiscriminate examination of members of a population to detect heterozygotes for serious disorders and counsel about the risks of marriages with other carriers, and by antenatal diagnosis where a married couple are both carriers; often sacrifices precision to simplicity and is most effectively applied to populations known to be at high risk.
(05 Mar 2000)
mass screening Organised periodic procedures performed on large groups of people for the purpose of detecting disease.
(12 Dec 1998)
vision screening Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from vision tests, which are given to evaluate/measure individual visual performance not related to a specific population.
(12 Dec 1998)
multiphasic screening The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people.
(12 Dec 1998)
prenatal screening Screening for the detection of foetal disease, usually by ultrasound examination or by testing amniotic fluid obtained by amniocentesis. Other screening techniques include testing maternal serum and placental biopsy.
(05 Mar 2000)
cytologic screening A screening for the detection of early disease, usually cancer, through microscopic examination of a cellular specimen by inspecting each cell and structure present, usually at ×100 magnification with a mechanical stage, so that all areas are screened; the findings are evaluated and significant abnormalities are flagged (e.g., by dotting the cover slip) for further evaluation by a cytopathologist. This screening is usually performed by a cytotechnologist, but at times is done by automated machine prescreening.
(05 Mar 2000)
screening Examination of people with no symptoms, to detect unsuspected disease.
(16 Dec 1997)
screening audiometry Rapid measurement of the hearing of an individual or a group against a predetermined limit of normalcy; auditory responses to different frequencies presented at a constant intensity level are tested.
(05 Mar 2000)
screening test Any testing procedure designed to separate people or objects according to a fixed characteristic or property.
(05 Mar 2000)
neonatal screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.
(12 Dec 1998)
newborn screening Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism.
(12 Dec 1998)
Denver Developmental Screening Test A scale used by psychologists and paediatricians to assess the developmental, intellectual, motor, and social maturity of children at any age level from birth to adolescence.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • screening
    üÁúÇϱâ;½É»ç;°¡¸®±â;Â÷Æä
  • maternal
    ¾î¸Ó´ÏÀÇ
  • maternal
    ¾î¸Ó´ÏÀÇ;¾î¸Ó´Ï´Ù¿î(opp,paternal)
  • maternal deprivation
    ¸ð¼ºÀû º¸È£ÀÇ ¹ÚÅ»;¸ð¼º »ó½Ç
  • serum
    Ç÷û
  • immune serum
    ¸é¿ª Ç÷û
  • serum
    Àå¾×;Ç÷û
  • truth serum
    Áø½É Åä·Î¾à (¸ÔÀ¸¸é Áø½ÉÀ» Åоî³õ´Â´Ù´Â ¾à)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á